louisiana semaglutide ban The Therapeutic Goods Administration has issued an urgent safety warning over the risk of suicidal thoughts linked to popular drugs used to treat type 2 diabetes and obesity. The affected drugs include Novo Nordisk, Eli Lilly Sending

La semaglutida es un medicamento agonista del receptor GLP-1 aprobado por la FDA para el tratamiento de la diabetes tipo 2 y el manejo crnico del peso en adultos con obesidad o sobrepeso

Novo Nordisk, the company that makes Ozempic, suggests avoiding fried, greasy or sweet foods if you struggle with nausea while taking the medication

Both programs make GLP-1 treatment more accessible for women, just in different ways

Frederiksen KS et al

Originally published at on September 12, 2023.

Concurrent lifestyle interventionsregular exercise, sleep optimization, stress management, and adequate hydrationdirectly reduce anxiety and improve GLP-1 tolerability